103 related articles for article (PubMed ID: 38848215)
1. Lineage specification in glioblastoma is regulated by METTL7B.
Constantinou M; Nicholson J; Zhang X; Maniati E; Lucchini S; Rosser G; Vinel C; Wang J; Lim YM; Brandner S; Nelander S; Badodi S; Marino S
Cell Rep; 2024 Jun; 43(6):114309. PubMed ID: 38848215
[TBL] [Abstract][Full Text] [Related]
2. METTL7B contributes to the malignant progression of glioblastoma by inhibiting EGR1 expression.
Xu L; Peng B; Wu H; Zheng Y; Yu Q; Fang S
Metab Brain Dis; 2022 Apr; 37(4):1133-1143. PubMed ID: 35254598
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of METTL7B Inhibits Proliferation of Human Clear Cell Renal Cancer Cells
Li W; Xu S; Peng N; Zhang Z; He H; Chen R; Chen D; Fan J; Wang X
Front Oncol; 2021; 11():634542. PubMed ID: 33718220
[TBL] [Abstract][Full Text] [Related]
4. METTL7B (methyltransferase-like 7B) identification as a novel biomarker for lung adenocarcinoma.
Ali J; Liu W; Duan W; Liu C; Song J; Ali S; Li E; Wang Q
Ann Transl Med; 2020 Sep; 8(18):1130. PubMed ID: 33240979
[TBL] [Abstract][Full Text] [Related]
5. METTL7B is a novel prognostic biomarker of lower-grade glioma based on pan-cancer analysis.
Jiang Z; Yin W; Zhu H; Tan J; Guo Y; Xin Z; Zhou Q; Cao Y; Wu Z; Kuang Y; Li C; Xie D; Huang H; Zhao M; Jiang X; Wang L; Ren C
Cancer Cell Int; 2021 Jul; 21(1):383. PubMed ID: 34281539
[TBL] [Abstract][Full Text] [Related]
6. Methyltransferase like 7B is a potential therapeutic target for reversing EGFR-TKIs resistance in lung adenocarcinoma.
Song H; Liu D; Wang L; Liu K; Chen C; Wang L; Ren Y; Ju B; Zhong F; Jiang X; Wang G; Chen ZS; Zou C
Mol Cancer; 2022 Feb; 21(1):43. PubMed ID: 35144642
[TBL] [Abstract][Full Text] [Related]
7. High Level of METTL7B Indicates Poor Prognosis of Patients and Is Related to Immunity in Glioma.
Xiong Y; Li M; Bai J; Sheng Y; Zhang Y
Front Oncol; 2021; 11():650534. PubMed ID: 33996568
[TBL] [Abstract][Full Text] [Related]
8. Characterization of METTL7B to Evaluate TME and Predict Prognosis by Integrative Analysis of Multi-Omics Data in Glioma.
Chen X; Li C; Li Y; Wu S; Liu W; Lin T; Li M; Weng Y; Lin W; Qiu S
Front Mol Biosci; 2021; 8():727481. PubMed ID: 34604305
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Potential of METTL7B in Glioma.
Fu R; Luo X; Ding Y; Guo S
Neuroimmunomodulation; 2022; 29(3):186-201. PubMed ID: 35034026
[TBL] [Abstract][Full Text] [Related]
10. Methyltransferase like 7B is upregulated in sepsis and modulates lipopolysaccharide-induced inflammatory response and macrophage polarization.
Huang D; Yan H
Bioengineered; 2022 May; 13(5):11753-11766. PubMed ID: 35603523
[TBL] [Abstract][Full Text] [Related]
11. METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung Cancer.
Liu D; Li W; Zhong F; Yin J; Zhou W; Li S; Sun X; Xu J; Li G; Wen Y; Wang J; Hong M; Cheng Z; Yuan J; Dai L; Sun J; Wang J; Qiu C; Wang G; Zou C
Front Pharmacol; 2020; 11():178. PubMed ID: 32180726
[TBL] [Abstract][Full Text] [Related]
12. METTL7B serves as a prognostic biomarker and promotes metastasis of lung adenocarcinoma cells.
Li R; Mu C; Cao Y; Fan Y
Ann Transl Med; 2022 Aug; 10(16):895. PubMed ID: 36110989
[TBL] [Abstract][Full Text] [Related]
13. Human METTL7B is an alkyl thiol methyltransferase that metabolizes hydrogen sulfide and captopril.
Maldonato BJ; Russell DA; Totah RA
Sci Rep; 2021 Mar; 11(1):4857. PubMed ID: 33649426
[TBL] [Abstract][Full Text] [Related]
14. METTL7A (TMT1A) and METTL7B (TMT1B) Are Responsible for Alkyl
Russell DA; Chau MK; Shi Y; Levasseur IN; Maldonato BJ; Totah RA
Drug Metab Dispos; 2023 Aug; 51(8):1024-1034. PubMed ID: 37137720
[No Abstract] [Full Text] [Related]
15. Glycolysis Modulation by METTL7B Shapes Acute Lymphoblastic Leukemia Cell Proliferation and Chemotherapy Response.
Zhang L; Liu X; Zhou S; Wang P; Zhang X
Hum Cell; 2024 Mar; 37(2):478-490. PubMed ID: 38294636
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional model of glioblastoma by co-culturing tumor stem cells with human brain organoids.
Azzarelli R; Ori M; Philpott A; Simons BD
Biol Open; 2021 Feb; 10(2):. PubMed ID: 33619017
[TBL] [Abstract][Full Text] [Related]
17. Novel Peripherally Derived Neural-Like Stem Cells as Therapeutic Carriers for Treating Glioblastomas.
Birbrair A; Sattiraju A; Zhu D; Zulato G; Batista I; Nguyen VT; Messi ML; Solingapuram Sai KK; Marini FC; Delbono O; Mintz A
Stem Cells Transl Med; 2017 Feb; 6(2):471-481. PubMed ID: 28191774
[TBL] [Abstract][Full Text] [Related]
18. SWIM tool application to expression data of glioblastoma stem-like cell lines, corresponding primary tumors and conventional glioma cell lines.
Fiscon G; Conte F; Paci P
BMC Bioinformatics; 2018 Nov; 19(Suppl 15):436. PubMed ID: 30497369
[TBL] [Abstract][Full Text] [Related]
19. Characterization of
Farkas C; Quiroz A; Alvarez C; Hermosilla V; Aylwin CF; Lomniczi A; Castro AF; Hepp MI; Pincheira R
Front Genet; 2021; 12():613808. PubMed ID: 33692826
[TBL] [Abstract][Full Text] [Related]
20. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
